Compare with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs DR. REDDYS LAB - Comparison Results

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES DR. REDDYS LAB ALKEM LABORATORIES/
DR. REDDYS LAB
 
P/E (TTM) x - 39.9 - View Chart
P/BV x 10.2 5.4 188.3% View Chart
Dividend Yield % 0.4 0.4 97.4%  

Financials

 ALKEM LABORATORIES   DR. REDDYS LAB
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
DR. REDDYS LAB
Mar-19
ALKEM LABORATORIES/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs1,5892,875 55.3%   
Low Rs1,2321,888 65.3%   
Sales per share (Unadj.) Rs417.5930.2 44.9%  
Earnings per share (Unadj.) Rs56.3117.4 47.9%  
Cash flow per share (Unadj.) Rs64.7185.8 34.8%  
Dividends per share (Unadj.) Rs12.7020.00 63.5%  
Dividend yield (eoy) %0.90.8 107.2%  
Book value per share (Unadj.) Rs292.9844.4 34.7%  
Shares outstanding (eoy) m119.57166.07 72.0%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x3.42.6 132.0%   
Avg P/E ratio x25.120.3 123.5%  
P/CF ratio (eoy) x21.812.8 170.0%  
Price / Book Value ratio x4.82.8 170.7%  
Dividend payout %22.617.0 132.4%   
Avg Mkt Cap Rs m168,653395,496 42.6%   
No. of employees `000NA22.0 0.0%   
Total wages/salary Rs m9,17133,562 27.3%   
Avg. sales/employee Rs ThNM7,032.8-  
Avg. wages/employee Rs ThNM1,527.9-  
Avg. net profit/employee Rs ThNM887.7-  
INCOME DATA
Net Sales Rs m49,915154,482 32.3%  
Other income Rs m1,6453,375 48.7%   
Total revenues Rs m51,561157,857 32.7%   
Gross profit Rs m8,48231,782 26.7%  
Depreciation Rs m1,00611,348 8.9%   
Interest Rs m671889 75.4%   
Profit before tax Rs m8,45122,920 36.9%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m0438 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6063,858 41.6%   
Profit after tax Rs m6,73119,500 34.5%  
Gross profit margin %17.020.6 82.6%  
Effective tax rate %19.016.8 112.9%   
Net profit margin %13.512.6 106.8%  
BALANCE SHEET DATA
Current assets Rs m27,062111,101 24.4%   
Current liabilities Rs m15,32458,973 26.0%   
Net working cap to sales %23.533.7 69.7%  
Current ratio x1.81.9 93.7%  
Inventory Days Days6779 83.8%  
Debtors Days Days4194 43.8%  
Net fixed assets Rs m12,610101,245 12.5%   
Share capital Rs m239830 28.8%   
"Free" reserves Rs m34,490139,406 24.7%   
Net worth Rs m35,027140,236 25.0%   
Long term debt Rs m1,21222,000 5.5%   
Total assets Rs m54,387224,656 24.2%  
Interest coverage x13.626.8 50.8%   
Debt to equity ratio x00.2 22.0%  
Sales to assets ratio x0.90.7 133.5%   
Return on assets %13.69.1 150.0%  
Return on equity %19.213.9 138.2%  
Return on capital %24.914.9 166.3%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Exports (fob) Rs m6,461NA-   
Imports (cif) Rs m1,540NA-   
Fx inflow Rs m6,56388,673 7.4%   
Fx outflow Rs m3,01219,104 15.8%   
Net fx Rs m3,55269,569 5.1%   
CASH FLOW
From Operations Rs m7,25928,704 25.3%  
From Investments Rs m1,864-7,727 -24.1%  
From Financial Activity Rs m-9,273-21,326 43.5%  
Net Cashflow Rs m-150-314 47.8%  

Share Holding

Indian Promoters % 66.9 25.5 262.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 5.4 613.0%  
FIIs % 0.0 35.3 -  
ADR/GDR % 0.0 18.5 -  
Free float % 0.0 15.3 -  
Shareholders   68,381 75,885 90.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SHASUN PHARMA  WYETH LTD  ABBOTT INDIA  UNICHEM LAB  PROCTER & GAMBLE HEALTH  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Flat; Power and Telecom Stocks Witness Buying(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

More Views on News

Most Popular

These 5 Smallcaps Deserve a Place in Your Coffee Can Portfolio(Profit Hunter)

Jul 28, 2020

When it comes to quality stocks, doing less is more.

Before You Buy Your First Electric Vehicle Consider Buying this Stock(Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

How to Buy Gold and Silver(Fast Profits Daily)

Jul 27, 2020

In this video I'll show you how to buy bullion the right way.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Aug 7, 2020 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS